VELYNTRA
Live / Allowed — Published for opposition (as of 17 Feb 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 24 May 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98568294
- Mark type
- Stylized text
- Filed
- 24 May 2024
- Published for opposition
- 17 Feb 2026
- Attorney of record
- G Patrick SAGE II
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of pain
Owner
- ESTEVE PHARMACEUTICALS, S.A., Barcelona, ES
- ESTEVE PHARMACEUTICALS, S.A., Barcelona, ES
Prior registrations
Prosecution history
- 18 Feb 2026 — TEAS POST PUBLICATION AMENDMENT RECEIVED
- 17 Feb 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Feb 2026 — PUBLISHED FOR OPPOSITION
- 11 Feb 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 21 Jan 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 13 Nov 2025 — SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
- 12 May 2025 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 12 May 2025 — LETTER OF SUSPENSION E-MAILED
- 12 May 2025 — SUSPENSION LETTER WRITTEN
- 03 May 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 02 May 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 02 May 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 29 Jan 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 29 Jan 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 04 Nov 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED